Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
European Journal of Haematology|September 13, 2002
Multiple gammac-receptor expression in adult T-cell leukemiaHirofumi Baba, Yasuaki Yamada, Naoki Mori, et al.International Journal of Hematology|January 26, 2019
Clinical features at transformation in adult T-cell leukemia-lymphoma with smoldering and chronic typesHiroaki Taniguchi, Yoshitaka Imaizumi, Yumi Takasaki, et al.Cancer Science|August 4, 2016
Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in NagasakiMasatoshi Matsuo, Masako Iwanaga, Hisayoshi Kondo, et al.Cancer Letters|May 18, 2005
Impact of p53 aberration on the progression of Adult T-cell Leukemia/LymphomaMasayuki Tawara, Simon J Hogerzeil, Yasuaki Yamada, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Risk of myelodysplastic syndromes in people exposed to ionizing radiation: a retrospective cohort study of Nagasaki atomic bomb survivorsMasako Iwanaga, Wan-Ling Hsu, Midori Soda, et al.European Journal of Haematology|June 29, 2012
A spindle cell variant of diffuse large B-cell lymphoma is characterized by T-cell/myofibrohistio-rich stromal alterations: analysis of 10 cases and a review of the literatureYoshizo Kimura, Fumiko Arakawa, Junichi Kiyasu, et al.British Journal of Haematology|December 22, 2017
Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in NagasakiMakiko Horai, Shinya Satoh, Masatoshi Matsuo, et al.Leukemia & Lymphoma|October 31, 2006
Survey of chemokine receptor expression reveals frequent co-expression of skin-homing CCR4 and CCR10 in adult T-cell leukemia/lymphomaHitomi Harasawa, Yasuaki Yamada, Kunio Hieshima, et al.Cancer Science|September 17, 2020
No clear survival benefit of azacitidine for lower-risk myelodysplastic syndromes: A retrospective study of NagasakiEo Toriyama, Tomoko Hata, Ken-Ichi Yokota, et al.Internal Medicine (Tokyo, Japan)|February 22, 2021
Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study GroupMasahiko Chiwata, Hidehiro Itonaga, Shinya Sato, et al.Pageof 3